Sales

AcuityMD

AI commercial intelligence platform for medical device sales teams

Visit AcuityMD

1 viewsPricing · PaidRising

The Falcoscan Intel Panel/AcuityMD · Sales

Live market data

Opportunity

Strong/ 100

Saturation

Contested/ 100

Wrapper Risk

Open/ 100

Signal

Rising

Market trend

The Brief

What AcuityMD does

AcuityMD is a medical device sales intelligence platform that helps MedTech commercial teams identify high-value prospects, manage territories, and forecast revenue. Its AcuityAI feature surfaces "next best actions" for sales reps, and the company says AI users are three times more likely to hit quota. AcuityMD says it is trusted by more than 500 medical device companies, including 16 of the top 20 in the sector. The company was founded by Michael Monovoukas, Robert Coe, and Lee Smith and is headquartered in Boston.

Builder’s Brief

AcuityMD is a sales tool on Falcoscan. AI commercial intelligence platform for medical device sales teams. Falcoscan rates AcuityMD with an Opportunity score of 74/100, a Saturation score of 44/100, and a Wrapper-risk score of 29/100. Market signal: rising. AcuityMD is founded in 2018, currently at Series_c stage. Pricing: Paid.

Market position · Sales

How AcuityMD compares in Sales

AcuityMD's opportunity score of 74 ranks #50 of 276 live Sales tools on Falcoscan, 10.1 points above the category average of 63.9. Its saturation score is 44/100, against a category average of 44.4. 86 of the 276 live Sales tools carry a hot signal, and Falcoscan has recorded 19 shutdowns in the category.